Obiageli Nnodu
CrispCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All?
Obiageli Nnodu is a professor of Hematology and Blood Transfusion and director of the Centre of Excellence for Sickle Cell Disease Research and Training at the University of Abuja.
She is national coordinator of the American Society of Hematology Consortium for Newborn Screening in Africa, Nigerian principal investigator at Sickle Pan African Research Consortium, Abuja, coordinator for SickleGenAfrica and co-principal investigator for the UK NIHR patient-centered management of sickle cell disease (SCD) in sub-Saharan Africa, and a UK Chevening Scholar.
Professor Nnodu has carried out many multi-institutional, multi-national research projects, including a multilateral Department for International Development-Development Partnerships in Higher Education project.
She serves as an expert on technical committees on non-communicable diseases. Her assessment of the level of implementation of the WHO AFRO’s Regional Strategy in SCD in sub-Saharan Africa highlighted the need for increased global funding for SCD.
She chairs the Sickle Cell Support Society of Nigeria and is a Fellow of the Nigerian Academy of Medicine.